Skip to main content
lexblog.com/lib/P46DA8BNviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Texas Responds to DEA Announcement Allowing Prescription of Controlled Substances via Telemedicine during COVID-19 Emergency",
    "url": "https://www.lexblog.com/2020/03/20/texas-responds-to-dea-announcement-allowing-prescription-of-controlled-substances-via-telemedicine-during-covid-19-emergency/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-P46DA8BN",
        "url": "https://www.lexblog.com/lib/P46DA8BN/"
    },
    "datePublished": "2020-03-20T17:57:57-04:00",
    "dateModified": "2024-05-17T09:58:33-04:00",
    "author": {
        "@type": "Person",
        "name": "Julian Rivera, Theresa Langley"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Husch Blackwell LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Healthcare Law Insights",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.healthcarelawinsights.com/?p=4363",
    "sourceStability": "may-move"
}